Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
50%
Artemisinin
100%
Clinical Trial
25%
Diseases
25%
Drug Discovery
25%
Drug Resistance
25%
Experimental Therapeutic
25%
Glucose 6 Phosphate Dehydrogenase
25%
Glucose 6 Phosphate Dehydrogenase Deficiency
25%
Infection
75%
Infectious Agent
25%
Malaria Falciparum
25%
Mouse Model
25%
Parasitosis
25%
Plasmodium
100%
Plasmodium falciparum
25%
Plasmodium Vivax Malaria
25%
Primaquine
50%
Proteasome
100%
Proteasome Inhibitor
50%
Tafenoquine
50%
Biochemistry, Genetics and Molecular Biology
Biochemistry
25%
Clinical Trial
25%
Drug Resistance
25%
G6PD Deficiency
25%
Genetics
25%
Glucose-6-Phosphate Dehydrogenase
25%
Infectious Agent
25%
Life Cycle
25%
Mouse Model
25%
Plasmodium
100%
Plasmodium falciparum
25%
Proteasome
100%
Proteasome Inhibitor
50%
Protein Catabolism
25%
Protein Complexes
25%
Immunology and Microbiology
Antimalarial Agent
16%
Drug Resistance
16%
Human Cell
16%
Infectious Agent
16%
Infectious Disease
33%
Life Cycle
16%
Mouse Model
16%
Parasite Protein
16%
Parasitic Disease
16%
Plasmodium
100%
Plasmodium falciparum
16%
Primaquine
33%
Proteasome
100%
Protein Complex
16%
Protein Degradation
16%
Tafenoquine
33%